Michael Stoeck

829 total citations
29 papers, 703 citations indexed

About

Michael Stoeck is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Michael Stoeck has authored 29 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Immunology and 6 papers in Oncology. Recurrent topics in Michael Stoeck's work include Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (6 papers) and Immunotherapy and Immune Responses (5 papers). Michael Stoeck is often cited by papers focused on Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (6 papers) and Immunotherapy and Immune Responses (5 papers). Michael Stoeck collaborates with scholars based in Germany, Switzerland and France. Michael Stoeck's co-authors include Sylvia Miescher, V von Fliedner, C Barras, Lifeng Qiao, L Barrelet, Klaus Resch, Daniela S. Bundschuh, H. Robson MacDonald, Degenhard Marx and Beate Schmidt and has published in prestigious journals such as The Journal of Immunology, FEBS Letters and Annals of the New York Academy of Sciences.

In The Last Decade

Michael Stoeck

28 papers receiving 683 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Stoeck Germany 13 316 207 180 125 104 29 703
LM Pelus United States 9 349 1.1× 317 1.5× 178 1.0× 116 0.9× 56 0.5× 14 1.0k
Masayuki Ishizaki Japan 13 367 1.2× 89 0.4× 130 0.7× 287 2.3× 111 1.1× 17 726
Cecilia Muñoz Spain 10 369 1.2× 195 0.9× 159 0.9× 54 0.4× 35 0.3× 17 745
Scot Middleton United States 13 133 0.4× 387 1.9× 176 1.0× 77 0.6× 160 1.5× 15 770
Annette Breedijk Netherlands 15 295 0.9× 147 0.7× 53 0.3× 76 0.6× 153 1.5× 26 682
Takaaki Fukuda Japan 17 241 0.8× 175 0.8× 70 0.4× 78 0.6× 90 0.9× 52 744
Bettina Sehnert Germany 13 275 0.9× 205 1.0× 111 0.6× 58 0.5× 44 0.4× 35 887
Mariangela Correa Brazil 10 246 0.8× 336 1.6× 134 0.7× 47 0.4× 33 0.3× 18 649
Asuka Inoue Japan 17 331 1.0× 169 0.8× 147 0.8× 42 0.3× 38 0.4× 41 691
R White United States 14 177 0.6× 282 1.4× 92 0.5× 119 1.0× 304 2.9× 22 910

Countries citing papers authored by Michael Stoeck

Since Specialization
Citations

This map shows the geographic impact of Michael Stoeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Stoeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Stoeck more than expected).

Fields of papers citing papers by Michael Stoeck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Stoeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Stoeck. The network helps show where Michael Stoeck may publish in the future.

Co-authorship network of co-authors of Michael Stoeck

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Stoeck. A scholar is included among the top collaborators of Michael Stoeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Stoeck. Michael Stoeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weber, Alexander, et al.. (2011). Optimisation of ITK inhibitors through successive iterative design cycles. Bioorganic & Medicinal Chemistry Letters. 21(6). 1852–1856. 11 indexed citations
2.
Obermeier, Florian, Martin Hausmann, Silvia Kellermeier, et al.. (2006). IL‐15 protects intestinal epithelial cells. European Journal of Immunology. 36(10). 2691–2699. 39 indexed citations
3.
Belvisi, Maria G., Daniela S. Bundschuh, Michael Stoeck, et al.. (2005). Preclinical Profile of Ciclesonide, a Novel Corticosteroid for the Treatment of Asthma. Journal of Pharmacology and Experimental Therapeutics. 314(2). 568–574. 40 indexed citations
4.
Stoeck, Michael, R. M. Riedel, Günther Hochhaus, et al.. (2004). In Vitro and in Vivo Anti-Inflammatory Activity of the New Glucocorticoid Ciclesonide. Journal of Pharmacology and Experimental Therapeutics. 309(1). 249–258. 87 indexed citations
5.
Stoeck, Michael, W. Krömer, & Volker Gekeler. (1998). Induction of IL-15 mRNA and Protein in A549 Cells by Pro-inflammatory Cytokines. Immunobiology. 199(1). 14–22. 14 indexed citations
6.
Hänsch, Gertrud Maria, Christof Wagner, Antje Bürger, et al.. (1995). Matrix protein synthesis by glomerular mesangial cells in culture: Effects of transforming growth factor β (TGFβ) and platelet‐derived growth factor (PDGF) on fibronectin and collagen type IV mRNA. Journal of Cellular Physiology. 163(3). 451–457. 54 indexed citations
7.
Schirrmacher, Volker, et al.. (1993). Specific Immunotherapy of Colorectal Carcinoma with Newcastle‐Disease Virus‐Modified Autologous Tumor Cells Prepared from Resected Liver Metastasis. Annals of the New York Academy of Sciences. 690(1). 364–366. 5 indexed citations
8.
9.
Stoeck, Michael, Rawleigh Howe, & H. Robson MacDonald. (1992). Distinct effects of phorbol esters and exogenous diacylglycerols in the induction of murine thymocyte proliferation. Journal of Cellular Physiology. 151(1). 8–12.
10.
Ferradini, Laurent, Sylvia Miescher, Michael Stoeck, et al.. (1991). Cytotoxic potential despite impaired activation pathways in T lymphocytes infiltrating nasopharyngeal carcinoma. International Journal of Cancer. 47(3). 362–370. 49 indexed citations
11.
12.
Stoeck, Michael, Sylvia Miescher, H. Robson MacDonald, & V von Fliedner. (1989). Transforming growth factors beta slow down cell‐cycle progression in a murine interleukin‐2 dependent T‐cell line. Journal of Cellular Physiology. 141(1). 65–73. 37 indexed citations
13.
Stoeck, Michael, Curzio Rüegg, Sylvia Miescher, et al.. (1989). Comparison of the immunosuppressive properties of milk growth factor and transforming growth factors beta 1 and beta 2.. The Journal of Immunology. 143(10). 3258–3265. 47 indexed citations
14.
Stoeck, Michael, Rosemary K. Lees, Márta Szamel, Giuseppe Pantaleo, & H. Robson MacDonald. (1989). Comparison of phorbol‐12‐myristate‐13‐acetate and dioctanoyl‐sn‐glycerol in the activation of EL4/6.1 thymoma cells. Journal of Cellular Physiology. 138(3). 541–547. 8 indexed citations
15.
16.
Miescher, Sylvia, Michael Stoeck, T L Whiteside, et al.. (1988). Altered activation pathways in T lymphocytes infiltrating human solid tumors.. PubMed. 20(2). 344–6. 12 indexed citations
17.
Miescher, Sylvia, Michael Stoeck, Lifeng Qiao, et al.. (1988). Preferential clonogenic deficit of CD8-positive T-lymphocytes infiltrating human solid tumors.. PubMed. 48(24 Pt 1). 6992–8. 81 indexed citations
18.
Stoeck, Michael, et al.. (1988). A sensitive, IL-2-independent, assay for IL-1. Journal of Immunological Methods. 107(1). 23–30. 14 indexed citations
19.
Miescher, Sylvia, Michael Stoeck, Lifeng Qiao, et al.. (1988). Proliferative and cytolytic potentials of purified human tumor‐infiltrating t lymphocytes. Impaired response to mitogen‐driven stimulation despite T‐cell receptor expression. International Journal of Cancer. 42(5). 659–666. 80 indexed citations
20.
Northoff, Hinnak, Michael Stoeck, & Peter H. Krammer. (1982). The Effect of Phorbol-Myristate Acetate and Concanavalin A on the Growth of Interleukin-2-Dependent T-Cell Lines. Immunobiology. 161(5). 464–475. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by LM Pelus Breakdown of academic impact, for papers by Masayuki Ishizaki Breakdown of academic impact, for papers by Cecilia Muñoz Breakdown of academic impact, for papers by Scot Middleton Breakdown of academic impact, for papers by Annette Breedijk Breakdown of academic impact, for papers by Takaaki Fukuda Breakdown of academic impact, for papers by Bettina Sehnert Breakdown of academic impact, for papers by Mariangela Correa Breakdown of academic impact, for papers by Asuka Inoue Breakdown of academic impact, for papers by R White
Rankless by CCL
2026